PTGS2 and allergic asthma: In addition, SG treatment could alleviate allergic asthma by reducing the inflammatory cells in bronchoalveolar lavage (BAL) fluid and by decreasing inflammatory factors, including IL-4, IL-5, IL-13, eotaxin, and IgE, which are linked with the decreased expression of iNOS and COX-2 [28].